Related Experiment Video
Updated: Jun 24, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Anemia management in chronic kidney disease
Barbara S Gillespie1, Jula K Inrig, Lynda A Szczech
1Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA.
Hemodialysis International. International Symposium on Home Hemodialysis
|January 30, 2007
Summary
Anemia in chronic kidney disease (CKD) is common. While erythropoietin therapy can help, current data caution against targeting normal hemoglobin levels due to inconsistent cardiovascular outcomes.
Area of Science:
- Nephrology
- Cardiology
- Hematology
Background:
- Anemia is prevalent in chronic kidney disease (CKD) due to erythropoietin deficiency.
- Erythropoietin therapy has been utilized for two decades to manage anemia in CKD patients, aiming to improve outcomes.
- Current guidelines for hemoglobin (Hb) targets in CKD anemia are primarily based on observational data.
Observation:
- Limited prospective randomized trials exist on anemia correction's impact on cardiovascular (CV) morbidity and mortality in high-risk CKD patients.
- Observational data suggest beneficial associations with erythropoietin therapy.
- Available trial data indicate caution against normalizing Hb levels in CKD patients due to potential adverse CV outcomes.
Findings:
- Controversy persists regarding optimal Hb targets for anemia correction in CKD.
- Inconsistent outcomes have been observed with varying degrees of anemia correction.
- Trial data suggest that raising Hb levels to near-normal physiological ranges may not improve, and could potentially worsen, CV outcomes in CKD patients.
Implications:
- The interpretation of population-level data requires careful consideration of study design, particularly distinguishing between observational and randomized trial evidence.
- Establishing ideal Hb target ranges for CKD anemia remains an evolving area requiring further research.
- A case study highlights the importance of critically evaluating evidence to guide individualized patient care regarding anemia management in CKD.
Related Concept Videos
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...